The collection and subsequent use of data for clinical, regulatory, and coverage decision-making in oncology is of great interest to many stakeholders, including providers, payors, patients, and regulators. Rising health care costs and continued concerns about safety and quality have resulted in the demand for more data and evidence by payors and providers alike. A common foundation of high-quality data that are available in real time can simultaneously be used to improve clinical care and yield quality measurements, both of which are high priorities for stakeholders.
In the summer of 2012, NCCN will host an invitation-only NCCN Policy Summit to discuss concepts including but not limited to databases, cohort studies, surrogate endpoints and clinical trial design, pharmacovigilance, and coverage with evidence development. Prior to the Policy Summit, NCCN will convene a multi-disciplinary, diverse Work Group to identify challenges and provide recommendations on the above mentioned topics, among other key challenges. Ultimately, the focus of this initiative is to advance the evidence base for cancer treatment and to examine the way evidence is generated, aggregated, and applied to decision-making.
| Quick Links |
|
|
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved